News Sentiment

9966 sentiment intelligence

Alphamab Oncology news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 53 Balanced news tone 6 relevant articles
Exchange HKG Hong Kong
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 7.66 Week of 10 Jul 2026
Weighted tone 53/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

68/100 classification confidence.

Company focus 6

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

+0.4% over one week, +7.9% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Neutral

Alphamab Oncology Reports Full Year 2025 Financial Results and Business Highlights

Market Reaction

Balanced read

47/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 68/100 classification
One-week reaction 0.4% Price digesting
Trend fit Trend inactive 7.9% over four weeks
Fair value 10.2% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 1
Neutral 5
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 6
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
BioPharma APAC 2
Market source 1
TipRanks 1
Oncodaily 1
Latham & Watkins LLP 1

Event Lens

What the news is about

Classified themes
Market update 3
Regulatory and legal 2
Earnings 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-6 of 6